Income Statement Adicon Holdings Limited
Equities
9860
KYG0086A1076
Healthcare Facilities & Services
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.900 HKD | -4.20% | -3.05% | -31.75% |
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Revenues | 2.74B | 3.38B | 4.86B | 3.3B |
Total Revenues | 2.74B | 3.38B | 4.86B | 3.3B |
Cost of Goods Sold, Total | 1.63B | 1.94B | 2.97B | 1.88B |
Gross Profit | 1.12B | 1.44B | 1.89B | 1.42B |
Selling General & Admin Expenses, Total | 596M | 753M | 836M | 756M |
R&D Expenses | 102M | 125M | 163M | 144M |
Other Operating Expenses | 4.59M | 5.06M | 6.22M | 13.82M |
Other Operating Expenses, Total | 702M | 883M | 1B | 914M |
Operating Income | 414M | 559M | 890M | 505M |
Interest Expense, Total | -19.64M | -16.33M | -63.37M | -86.32M |
Interest And Investment Income | 3.76M | 6.29M | 8.87M | 20.16M |
Net Interest Expenses | -15.88M | -10.04M | -54.5M | -66.16M |
Currency Exchange Gains (Loss) | 1.43M | -50K | -6.74M | -8.2M |
Other Non Operating Income (Expenses) | -9.96M | -27.61M | 4.83M | -30.74M |
EBT, Excl. Unusual Items | 390M | 521M | 834M | 400M |
Gain (Loss) On Sale Of Investments | -32.56M | -39.7M | -112M | -57.86M |
Gain (Loss) On Sale Of Assets | -1.73M | -2.92M | -1.75M | -3.77M |
Other Unusual Items | 2.44M | -61.53M | 100M | 11.48M |
EBT, Incl. Unusual Items | 358M | 417M | 821M | 349M |
Income Tax Expense | 68.73M | 94.95M | 136M | 87.05M |
Earnings From Continuing Operations | 289M | 322M | 685M | 262M |
Net Income to Company | 289M | 322M | 685M | 262M |
Minority Interest | -5.33M | -6.76M | -4.09M | -27.44M |
Net Income - (IS) | 284M | 316M | 681M | 235M |
Net Income to Common Incl Extra Items | 284M | 316M | 681M | 235M |
Net Income to Common Excl. Extra Items | 284M | 316M | 681M | 235M |
Per Share Items | ||||
Net EPS - Basic | 0.49 | 0.5 | 1.04 | 0.34 |
Basic EPS - Continuing Operations | 0.49 | 0.5 | 1.04 | 0.34 |
Basic Weighted Average Shares Outstanding | 578M | 631M | 653M | 691M |
Net EPS - Diluted | 0.48 | 0.5 | 0.96 | 0.31 |
Diluted EPS - Continuing Operations | 0.48 | 0.5 | 0.96 | 0.31 |
Diluted Weighted Average Shares Outstanding | 587M | 631M | 706M | 717M |
Normalized Basic EPS | 0.41 | 0.51 | 0.79 | 0.32 |
Normalized Diluted EPS | 0.41 | 0.51 | 0.73 | 0.31 |
Payout Ratio | - | 143.43 | 127.06 | - |
Supplemental Items | ||||
EBITDA | 479M | 645M | 1.02B | 611M |
EBITA | 414M | 560M | 892M | 512M |
EBIT | 414M | 559M | 890M | 505M |
EBITDAR | 492M | 659M | 1.04B | 628M |
Effective Tax Rate - (Ratio) | 19.19 | 22.76 | 16.56 | 24.92 |
Total Current Taxes | 82.61M | 113M | 175M | 77.95M |
Total Deferred Taxes | -13.88M | -18.35M | -39.19M | 9.1M |
Normalized Net Income | 238M | 319M | 517M | 222M |
Interest on Long-Term Debt | 10.83M | 10.62M | 13.7M | 12.72M |
Supplemental Operating Expense Items | ||||
Selling and Marketing Expenses | 359M | 490M | 553M | 485M |
General and Administrative Expenses | 237M | 263M | 282M | 271M |
Research And Development Expense From Footnotes | 102M | 125M | 163M | 144M |
Net Rental Expense, Total | 13.08M | 13.83M | 13.39M | 17.1M |
Imputed Operating Lease Interest Expense | - | 2.05M | 4.68M | 7.75M |
Imputed Operating Lease Depreciation | - | 11.78M | 8.7M | 9.36M |
Stock-Based Comp., Other (Total) | 63.6M | 37.32M | 15.05M | 17.05M |
Total Stock-Based Compensation | 63.6M | 37.32M | 15.05M | 17.05M |